Cancer drug, when combined, boosts death risk
The cancer drug Avastin, also known as bevacizumab, is linked to a higher risk of death when combined with chemotherapy, said a study in the Journal of the American Medical Association.
The cancer drug Avastin, also known as bevacizumab, is linked to a higher risk of death when combined with chemotherapy, said a study in the Journal of the American Medical Association.
Continuing with effort to educate and inform the medical fraternity, Escorts Heart Institute and Research Centre Ltd. (EHIRCL), commissioned a two-day Cardiac seminar.